No increase in subtrochanteric or diaphyseal femur fractures was seen with denosumab use compared with bisphosphonates in 4 ...

Adults with osteoporosis prescribed the antiresorptive denosumab were no more likely to sustain an atypical femur fracture ...

Denosumab therapies are used to increase bone mass and treat osteoporosis, as well as address bone complications in cancer.

A major UK-based study has found that denosumab, a widely used osteoporosis medication, does not raise the risk of atypical femur fractures compared with bisphosphonates over four years. The result ...

A large real-world study of nearly 300,000 osteoporosis patients found no increased risk of atypical femur fractures with denosumab compared to bisphosphonates. The findings, presented at the 2026 ...

The bone metastasis in solid tumors market is expanding due to rising incidences of metastasizing solid tumors like breast, prostate, lung cancer, and renal cell carcinoma. This growth is fueled by ...

Samsung Bioepis Co., Ltd. today released its Second Quarter 2026 Biosimilar Market Report, marking the thirteenth edition of ...

Also, since I have a history of dental problems, how can I get off Prolia in the future and still protect my bones? -- L.L.

Waist Size Can Signal Risk for Heart Disease in T1D A higher waist-to-height ratio is independently linked to an increased risk for coronary artery disease in patients with type 1 diabetes, according ...

I’m a 79-year-old female who’s in good health. I am 5 feet tall and weigh 95 pounds, and I’m very active. I’ve been taking Prolia for the past two to three years for osteoporosis, which has since ...